The drug targeted inflammation, and its shocking failure has experts questioning whether inflammation really does cause heart disease.
A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease
The New York Times – Business:
This post first appeared in The New York Times – Business. Read the original article.